Navigation Links
CareFusion Moves First Quarter Earnings Announcement to November 5
Date:11/3/2009

SAN DIEGO, Nov. 3 /PRNewswire-FirstCall/ -- CareFusion Corporation (NYSE: CFN), a leading, global medical device company created on Sep. 1, 2009 through the spinoff of Cardinal Health's clinical and medical products businesses, today said it will release its first quarter results and host a conference call on Thurs., Nov. 5, 2009 at 8:30 a.m. EST, earlier than the previously announced earnings date.

The company is changing the date of its earnings announcement to coincide with Cardinal Health's first quarter earnings release. CareFusion was part of Cardinal Health for two months of the quarter, and Cardinal Health will present CareFusion results as part of its first quarter discontinued operations. By moving up the earnings release date, the company is seeking to avoid any potential confusion as a result of Cardinal Health's partial presentation of CareFusion results in its discontinued operations, which will differ from the company's reported results.

The CareFusion earnings webcast and conference call will now take place on Nov. 5, 2009 at 8:30 a.m. EST to discuss results for its first quarter of fiscal 2010, ended on Sep. 30, 2009. To access the call and corresponding slide presentation, visit www.carefusion.com on the Investor Relations section under "Calendar of Events," or dial 800-510-9836 or 617-614-3670, passcode 54900921. Log on at least 15 minutes before the call begins to register and download or install any necessary audio software.

A replay of the conference call will be available at 11 a.m. EST on Nov. 5, 2009 through 11:59 p.m. EST on Nov. 7, 2009 and can be accessed by dialing 888-286-8010 or 617-801-6888, passcode 54800850.

CareFusion previously planned to announce on Nov. 10, 2009 at 5 p.m. EST.

About CareFusion Corporation
'/>"/>

SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CareFusion Shipping Ventilators to CDC for National Emergency Preparedness
2. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
3. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
4. GHX Health ConneXion(TM) Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption
5. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
6. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
7. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
8. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
9. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
10. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
11. Corgenix to Host Conference Call to Discuss Fiscal 2010 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/15/2014)... 15, 2014  A novel wearable injector slightly larger than an ... patients to self-inject prescription drugs in the large doses required ... diseases, autoimmune deficiencies, and genetic disorders.  An ... by 2018, according to analysts.   Many of these drugs will ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/18/2014)... A new study in the American Journal of ... searches reveals a recurring pattern that could be leveraged ... from San Diego State University, the Santa Fe Institute, ... Google searches (searches that included the term healthy and ... U.S. from 2005 to 2012. They found that on ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... to a study published today in PLOS Pathogens ... where malaria is common can mount an immune response ... to avoid repeated bouts of high fever and illness ... their bloodstream. The findings may help researchers develop future ... the malaria parasite. , Each year, approximately 200 million ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... of The Royal Marsden Hospital Manual of Clinical Nursing ... format that organises 15 key chapters into four key ... on areas such as risk management and preparing patients ... from the world-renowned UK centre of excellence, the Manual ...
... HealthDay Reporter , SUNDAY, April 3 (HealthDay News) -- Diabetes ... suggests an increased risk of cancer can be added to that ... had an 8 percent increased risk of developing cancer generally, while ... of prostate cancer were excluded from the calculation. The risk ...
... 4 (HealthDay News) -- Taking aspirin even once per month, ... a marked drop in the risk of developing pancreatic cancer, ... was linked to a 26 percent reduction in the risk ... of heart disease, was associated with an even greater drop ...
... be assessed by examining the epithelial cells found in ... the AACR 102nd Annual Meeting 2011, held April 2-6. ... provide a personalized assessment of breast cancer risk, said ... veterinary and animal sciences at the University of Massachusetts ...
... Prostate cancer is the second leading cause of cancer-related death ... reduced the number of deaths from the disease. By ... risk for aggressive disease or diagnosis at a young age, ... screening approach. For that reason, scientists have been looking for ...
... (March 29, 2011) Medicare coverage and nationwide ... as virtual colonoscopy, has tripled in recent years, according ... Journal of the American College of Radiology ... produce a three-dimensional visualization that permits a thorough and ...
Cached Medicine News:Health News:Patient's journey format drives new edition of vital student nurse manual 2Health News:Patient's journey format drives new edition of vital student nurse manual 3Health News:Add Cancer to Health Risks of Diabetes: Study 2Health News:Add Cancer to Health Risks of Diabetes: Study 3Health News:Monthly Aspirin Use Linked to Lower Pancreatic Cancer Risk 2Health News:Monthly Aspirin Use Linked to Lower Pancreatic Cancer Risk 3Health News:Breast milk may provide a personalized screen of breast cancer risk 2Health News:MicroRNA variations associated with earlier prostate cancer diagnosis in African-American men 2Health News:Nationwide utilization of virtual colonoscopy triples, study suggests 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: